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ABSTRACT
International Journal of Exercise Science 13(2): 744-754, 2020. Supplements are widely used in

recreational and professional participants; however, their claimed benefits are hardly to test. This study compared
the total lifted numbers and post-exercise estimated MVO2 while subjects were treated with either Muscle Sentry®
(MS) or placebo (PL), in a 7-day washout period. Participants (11 women, 10 men, 20-24 years) performed 3 sets to
failure chest and leg press exercises at 8 RM with 2 min rest between sets. Each exercise was performed four times
(2 × MS, 2 × PL) at the same time of the day separated by 48 h. The supplementation was ingested 40 min prior to
perform the exercise. Prior to the exercise and immediately after each set, both HR and BP were obtained. The rate
pressure product (RPP) was then calculated to determine estimated MVO2. Daily RPP and total weight lifted (chest
+ leg) for each supplementation were averaged. Normalized RPP was the ratio of averaged RPP and averaged total
weight lifted. No treatment effect on chest, leg and total lift numbers, normalized post RPP (NPRPP), normalized
RPPdiff (NRPPdiff) (p=0.94, 0.86, 0.87, 0.87, 0.43 respectively); No treatment effect on total lift numbers, NPRPP,
NRPPdiff for gender (p=0.87, 0.95, 0.96 respectively). Ingestion of Muscle Sentry® 40 min prior to do 3 sets to failure
of both chest and leg presses had no effect upon either total lift numbers or estimated MVO2. This suggests that, in
some instances, the benefits of Muscle Sentry® are less than those claimed by the manufacturer.
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INTRODUCTION
Our laboratory recently published a study that determined if Muscle Sentry® (Muscle Sentry
LLS, Cleveland, OH) would increase muscle stamina (i.e. endurance) on both the basis of a single
task and a repeated task (2). The main finding from that investigation was that the number of
lifts did not differ between the Muscle Sentry® and placebo treatments for either the initial or
the repeated sets. Thus, it appeared that the Muscle Sentry® had no influence upon stamina
when doing a task designed to fatigue a muscle after 2 minutes of work.
In retrospect, since some of the ingredients (Table 1.) found in this supplement have shown
positive effects in work of short duration and higher intensity, it is still possible that this
supplement will have an effect if used in different work scenarios. Muscle Sentry® purported
benefits upon stamina arise from ingredients that include various minerals complexed with
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lactate and red cinchona bark powder, a source of quinine. Morris (14) has pointed out that
exogenous lactate could be used as an energy substrate and as a buffering agent. Moreover,
ingestion has been shown to increase blood pH, bicarbonate levels and increase time to
exhaustion in short, high-intensity work bouts. On the other hand, Muscle Sentry® is unique in
that it contains red cinchona bark powder, a source of quinine. Gam et al. (5) have shown that
ingesting a 2mM solution of quinine improved the mean power output during a 30 s cycling
sprint.
Given that the ingredients found in Muscle Sentry® have been found to be beneficial in intense
work bouts lasting ≤30 seconds, it is quite possible that the negative findings of our original
study were due to the work lasting two minutes or 2.5 times longer than previous studies that
showed positive effects. Therefore, the purpose of this study was to investigate the effects of
Muscle Sentry® upon the amount of total lift numbers on repeated high-intensity short duration
work. In addition, since Muscle Sentry® manufacturer’s claim that using this supplement leads
to increased cardiovascular efficiency, we also investigated the supplement’s effect upon
myocardial work. In this context, we hypothesized that intake of Muscle Sentry® would increase
total muscle lift numbers and estimated MVO2.
Table 1. Muscle Sentry® active ingredients.
Supplement
Niacin
Pyridoxine HCL (vitamin B6)
Calcium Lactate
Magnesium Lactate
Zinc Oxide
Manganese Lactate
Potassium Chloride
Red Cinchona Bark Powder

Serving Amount
50 mg
9 mg
32.5 mg
50 mg
25 mg
16 mg
50 mg
600 mg

METHODS
Participants
Participants consisted of 11 female (age = 21 ± 1 y, height = 161 ± 8 cm, body mass = 61 ± 9 kg;
mean ± standard deviation) and 10 male (age = 22 ± 1 y, height = 180 ± 4 cm, body mass = 73 ±
28 kg; mean ± standard deviation) physical education college students. Inclusion criteria: nonresistance trained, healthy, normotension (<120/80 mm Hg), no supplements or medication
intake for more than one year. Exclusion criteria: pre-hypertension (between 120/80 mm Hg
and 139/89 mm Hg), hypertension (>140/90 mm Hg), cardiovascular disease and/or obesity
(BMI >30.0). This research was carried out fully in accordance to the ethical standards of the
International Journal of Exercise Science (16) . Informed consent (written and verbal) was
obtained from each participant before commencing the experiment, and the appropriate
institutional human participant review committee approved the study. The participants were
not allowed to see the results until the study was completed. The number of participants needed
for a statistical power of β=0.20 was determined using an online calculation website
(www.sample-size.net)
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Protocol
Study Overview: Participants visited a weight room 5 times on different days separated by a
minimum washout of seven days. On all experimental testing days, each participant performed
3 sets to failure on both a seated chest press and a leg press machine. The first experimental day
consisted of the participants performing the chest and leg presses to determine their 8 repetitions
maximum (8RM) weight. Days 2-5 consisted of doing 3 sets to failure with the 8RM weight for
both chest and leg presses. An 8 RM was chosen because a common resistance training program
consists of doing 3 sets of 8-10 reps. In a randomized counter-balanced manner, for two days the
lifts were performed on Muscle Sentry®, while for the other two days were performed on a
placebo. The dose for Muscle Sentry® was based upon body mass (i.e. 1 capsule for body
weights <160 lbs.; 2 capsules for body weights between 160 lbs. and 240lbs.; and 3 capsules for
body weights >240 lbs.). The placebo (powdered cellulose) consisted of the same amount of pills
and these pills were similar in shape and color to Muscle Sentry®. In addition to count the total
number of lifts, heart rate and blood pressure were measured at the beginning and end of each
set to failure.
Muscle 8RM and Stamina Test Protocol: As stated, the first experimental testing day consisted
of each participant performing an 8RM on the chest press and leg press machine. The chest press
was performed seated on a Body Masters vertical chest press machine (Body Masters Sports
Industries Inc., Rayne, LA, USA). The initial weight was set at 75% of body mass. After
performing 8 lifts at this weight, the participant rested for two minutes with the next lift
increased incrementally by multiples of 44 N (10 lbs.). Following a 2- minute rest, each
succeeding 8 repetitions set was incremented by 44 N (10 lbs.) until failure to complete 8
repetitions. For all repetitions, participants were instructed to push upward until they reached
full elbow extension as quickly as possible. Once full extension was reached, each person was
instructed to return as quickly as possible to the starting position while making sure that the
weight plates contacted the stationary (unmoved) plates.
The leg press was performed in a seated position using a Body Masters leg press machine (Body
Masters Sports Industries Inc., Rayne, LA, USA). Prior to beginning the test, participants were
seated in the apparatus with the seat position being adjusted so that the individuals starting
knee angle approximated 60o. The participants were instructed to push on the footplate until
they reached full knee extension as quickly as possible. Once full extension was reached, it was
instructed to return as quickly as possible to the starting position while making sure that the
weight plates contacted the stationary (unmoved) plates. The initial weight was set at 150% of
body mass, and the procedure was the same as that used for the chest press. The only difference
was that the ensuing 8 repetitions set was increased incrementally by multiples of 66 N (15 lbs.)
after each 2-minute rest.
For the subsequent 4 experimental testing days (day 2-5), participants reported to the laboratory
2 hours post-prandial and were instructed to consume either the Muscle Sentry® or placebo
supplement. Following supplement consumption, all participants rested quietly in the
laboratory for 40 minutes. Once the rest period was completed and depending upon which lift
was scheduled to be first, participants began a standardized warm-up by performing 8-reps at
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50% of their 8RM on either the chest press or leg press. Right after warmup, each participant
performed 3 sets to failure using 8RM, with two minutes rest between sets. Upon completion of
the 3-set lift, a 5-minute rest was taken. Once the 5 minutes rest was completed, participants
performed a secondary warm-up of 8 reps at 50% of 8RM on the opposite lift from which they
performed first. The same procedure was proceeded for the succeeding press. To ensure that all
lifts were performed correctly and without too much rest, two members of the experimental
team watched the subject to ensure their joints were full extended and then the weight plates
returned to the starting position. These two investigators also ensured that each extension and
flexion were done without any rest at either full extension or at weight plate touch. A third
individual who was unaware of the supplement taken that day counted the number of lifts.
Failure was set at the lift at which the person could not reach full (elbow or knee) extension.
Besides improving stamina, the manufacturer claims that the supplement improves
cardiovascular efficiency. To test this, it was decided to compare the post-exercise rate pressure
product (the product of heart rate and systolic blood pressure). The rate pressure product (RPP)
has been shown to be a reliable and meaningful predictor of myocardial oxygen consumption
(MVO2) during static and dynamic exercise (18). Therefore, heart rate (HR) and blood pressure
(BP) were obtained just prior to commencing and immediately after each set to failure. HR and
BP were measured using an automated device (Omron BP710, Omron Healthcare Inc.,
Bannockburn, IL, USA) which had previously been shown to provide reliable and accurate
values (17). Since HR and BP vary with work volume, for analysis the post-RPPs were
normalized by dividing the RPP by the total weight lifted in each respective lift.
Statistical Analysis
The variables of interest were total chest, total leg, and total body lift numbers, normalized post
RPP (NPRPP), and normalized pre and post exercise rate pressure product difference
(NRPPdiff). A one-way ANOVA was used to compare the treatments effect on each of the
aforementioned variables. A two-way (gender × treatment) ANOVA was used to test the
treatment effect on lift numbers by gender. A two-way (gender × RPP) ANOVA was used to test
treatment effect on NRPPdiff, NRPP in gender. Tukey test was used for the Post Hoc analysis, for
any significant differences. Statistical significance was set at alpha level as 0.05. All analyses
were conducted by using SAS software (SAS 9.4, SAS Institute Inc., NC, USA).
RESULTS
The total chest, total leg and total body lift numbers for both treatments are depicted in Figure
1. There were no significant differences for treatment effect on chest lift (p=0.94), leg lift (p=0.86)
and whole body lift numbers (p=0.87). In addition, there was no significant difference (p>0.05)
between the number of repetitions (lifts) for both within and between treatment days for each
set (i.e. set 1, set 2, and set 3 had a statistically similar number of lifts in all instances).

International Journal of Exercise Science

747

http://www.intjexersci.com

Int J Exerc Sci 13(2): 744-754, 2020

Figure 1. Total Lift Numbers. There was no significant difference between treatments and lift numbers (MS: Muscle
Sentry®).

There was no significant difference in treatment effect on gender, for chest lift numbers (p=0.87),
leg lift numbers (p=0.95), and whole body lift numbers (p=0.96) (Figure 2).
Finally, there was no significant difference between the treatments on either NRPPdiff or NPRPP
(p=0.43, 0.87 respectively) (Figure 3). There was, however, a significant difference between
gender on NPRPP (F=35.22, p<0.001), independent of treatments. Furthermore, there was a
significant difference between gender on NRPPdiff (F=7.77, p<0.008) (Figure 4), meaning post
RPP increased more in females than that in males.
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Figure 2. Treatment on different lift numbers for gender. There was no significant difference between treatment
effect on lift numbers in genders (MS: Muscle Sentry®.).
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Figure 3. Treatment on NPRPP and NRPPdiff, there was no significant treatment difference on normal post RPP
and normal RPP difference.

Figure 4. The difference of NPRPP and NRPPdiff for Gender. There was significant gender difference in normalized
post RPP and normalized RPP (M: male, F: female; ¥, # P<0.05).
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DISCUSSION
The goal of this study was to determine if ingestion of Muscle Sentry® would increase the
amount of lift numbers on repeated high-intensity short duration exercise. The main finding
was that Muscle Sentry® did not have any statistically significant effects on the magnitude of
high-intensity work performance for an exercise program using chest press and leg press
machines. Additionally, Muscle Sentry® did not result in improving myocardial work capacity.
Taken together with our lab’s previous study (2) of a lack of an increase in muscle stamina with
Muscle Sentry®, we can conclude again that Muscle Sentry® does not have any effect on muscle
work or myocardial work performance when performing resistance exercise at either a
moderate-intensity, long-duration bout, or high-intensity, short-duration bout.
High-intensity, short-duration exercise requires maximal or near-maximal intensity efforts
resulting in rapid changes in the intramuscular metabolic profile (12), as of which these changes
are accompanied by muscle fatigue (3). Scholars have demonstrated that high-intensity, shortduration exercise induced fatigue can be contributed to an accumulation of potassium ions (K+)
in the interstitium of the muscle cell (25), decreased release/uptake of calcium ions (Ca2+)
from/to the sarcoplasmic reticulum (11), depletion of energy substrates, and the accumulation
of metabolites within the muscle cell (24). Junior and his colleagues (12) have demonstrated that
muscle pH homeostasis is mainly regulated by intracellular, extracellular, and dynamic
buffering system during high-intensity, short-duration exercise (12). Lactate supplementation
has been suggested to increase extracellular buffering capacity (26), but studies related its effect
to exercise performance during high-intensity exercise are controversial. For example, Van
Montfoort et al. (26) reported participants’ exercise capacity improved by 1.7%, following a run
to exhaustion supplemented with a dose of 400 mg·kg-1 body mass (BM) of sodium lactate.
Furthermore, Morris et al. (15) found that supramaximal multiple bout cycling time to
exhaustion and total work increased by 17% when the cyclists were supplemented with 120
mg·kg-1 BM calcium lactate. However, Painelli and his colleagues (21) reported that neither 150
mg·kg-1 BM nor 300 mg·kg-1 BM of calcium lactate improved high- intensity intermittent
performance in the form of three upper-body arm-crank bouts. One potential explanation for
the inconsistence in findings could be related to the individual exercise protocols (12).
Furthermore, the aforementioned investigations administrated similar high-dose, therefore,
providing doubt and further controversy on the efficacy of lactate supplementation (12). On the
other hand, the dose recommended by Muscle Sentry® and used in current study, was much
less than the amount consumed in the aforementioned studies. Therefore, it is reasonable to
conclude that Muscle Sentry® would not increase performance of high-intensity, short-duration
exercise.
Red cinchona bark is a source of quinine that has been used since the early 1600s to treat malaria
(1). However, the therapeutic function of quinine is equivocal. On one side, quinine is a cinchona
alkaloid that belongs to the aryl amino alcohol group of drugs (10), with alkaloid being known
to stimulate cardiovascular and neurological function resulting in decreased sensations of
fatigue during physical stress (23). Thus, quinine has the potential to improve exercise
performance. Unfortunately, quinine has a low therapeutic index with adverse effects with its
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use being substantial (20). One common side effect is hypoglycaemia (plasma glucose
concentration <2.8 mmol/l), and occurs in up to 32% of patients receiving quinine therapy (19).
There are scant studies relating the ergogenic effect of quinine on exercise performance, and
those results are inconsistence. For example, Gam et al. (5) found that a combination of mouth
rinsing and ingestion of a 2-mmol·L-1 bitter quinine solution immediately before a maximal 30s
cycling sprint improved mean and peak power output. In another study, Gam and colleagues
(7) found that motor-evoked potentials (MEPs) were significantly increased by 16%
immediately after mouth rinsing and ingestion with the same 2-mmol·L-1 quinine solution. They
further suggested that the increased MEPs were the cause of the improvement of maximal
cycling sprint performance. The conclusions of the above studies were based on the theory that
a bitter solution may activate emotional and motor areas of the brain, as well as the autonomic
nervous system, all of which might have impacted the maximal sprint performance (6).
However, since Muscle Sentry® is an encapsulated supplement, it cannot have a similar
ergogenic effect as the supplements used in aforementioned studies. On the other hand, Gam et
al. (8) did not find the improvement of 30s cycling sprinting performance, when rinsing mouth
only with higher concentration 10-mmol·L-1 of quinine solution. Moreover, in contrast to the
findings of enhanced MEPs (5, 7), Fung and Holbrook (4) noted that quinine administration
showed a decrease in the excitability of the motor end-plate region resulting in a reduced
response to repetitive nerve stimulation. Additionally, there are no studies supporting the
manufacturer’s claim that quinine could be an enabler to improve the performance of other
supplements (9). Hence, it is reasonable to conclude that Muscle Sentry® has no significant
effects on high-intensity short duration resistance exercise.
The current study did not find any significant effect of Muscle Sentry® on cardiovascular
efficiency, which contrasted Peacock et al. (22) who reported a significant mean increase of 3
ml·kg-1·min-1 in VO2max following ingestion of Muscle Sentry®. However, VO2max and MVO2 do
not necessarily change in parallel with various exercises (18). Thus, one cannot simply conclude
any improvement in VO2max due to ingestion of Muscle Sentry® will increase cardiovascular
efficiency. Interestingly, the current study showed women had higher amount of NPRPP and
NRPPdiff (p=0.001, 0.008 respectively) than that of men independent of treatments. This suggests
that the women experienced more cardiac stress after the high-intensity short duration
resistance exercises. The current finding supports a previous study that the female’s response
to upper extremities isometric exercise was higher than that of the males (i.e. the women had
higher RPPs) (13). However, since the exercise protocol was different in these studies (concentric
vs. isometric); it is possible that the mechanisms would also be varied.
Finally, it should be noted that the study was designed to investigate the effect of Muscle
Sentry® on muscle stamina of untrained people. Since its effect on trained individuals was not
examined, Muscle Sentry® may have a significant different effect upon these two populations.
We hypothesized, however, that the benefits of Muscle Sentry® would be better explored by
using people who could benefit the most from enhanced stamina, i.e. the untrained or
individuals at the lower-end of the stamina continuum. Another limitation of this study was
only two exercises were utilized; a number less than normal seen in a regular resistance exercise
training (i.e. 5-10 lifts in most cases). Therefore, further studies are needed to examine the effect
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of Muscle Sentry® on trained people with multiple sets and more resistance exercises. Ingestion
of Muscle Sentry® did not increase exercise performance or heart function during high-intensity
short duration resistance exercise.
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